What is the Fiscal Year for Lipocine?
Date: November 14, 2026
Lipocine's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Salt Lake City, Utah, United States
Industry
Manufacturing, Pharmaceuticals Manufacturing
Stock Symbol
LPCN
Website
https://lipocine.comDescription
Lipocine Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. The company develops drugs based on Hydroance, a drug delivery technology. It primarily focuses on developing oral versions of several hormones for use in men and women health. The company’s lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. It also offers custom drugs for pharmaceutical/biotechnology companies. Lipocine Inc. was founded in 1997 and is headquartered in Salt Lake City, Utah.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Lipocine and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.